Skip to main content


Table 1 Characteristics of studies reporting adherence to ART in Cameroon

From: Trends and determining factors associated with adherence to antiretroviral therapy (ART) in Cameroon: a systematic review and analysis of the CAMPS trial

Reference Year City Study design (sample size) Adherence rate Method Cost of ART/month for that year in USD*
Laurent et al. 2000-2003 Douala Cross-sectional retrospective (788) <50% μ Scheduled visits attended 128
Kouanfack et al. 2002-2003 Yaoundé Prospective cohort (60) 88.7%, (97.5%) Biological markers, (Self Report) 51.2 (free for participants)
Mosoko et al. 2002-2005 Limbe Cross-sectional retrospective α (2920) 10.1% Scheduled visits attended 51.2
Boyer et al.[28] 2006 Yaoundé Cross-sectional (532) 56.6% Self Report β 12.8
Rougemont et al. 2006 Yaoundé Prospective cohort (312) 64% (78%) Pharmacy data (Self report) 12.8
Boyer et al.[32] 2006-2007 Multiple locations Cross-sectional (3151) 53.9% Self report β 12.8
Roux et al. 2006-2008 Yaoundé Prospective cohort (401) 61-73% Self report β 12.8
Mahy et al. 2007-2008 Tokombere Cross-sectional (56) 95% (80%) self report β (Pharmacy data) 0
Mbopi-Keou et al. 2010 Dschang Cross-sectional (356) 80.2% (48.7) Self report β (Pharmacy data) 0
CAMPS 2010 Yaoundé Cross-sectional (200) 90.5% Self report β 0
  1. *Costs vary per regimen, the highest costs are reported.
  2. α Cross- sectional analysis of previously collected data without planning for needs of an investigation.
  3. β All methods in which all information used to measure adherence was obtained by interviewing the participant with either one question or a series of questions.
  4. μ 50% was imputed to represent the trend graphically.